First Clinical Results for PSMA-Targeted alpha-Therapy Using (225)Ac-PSMA-I&T in Advanced-mCRPC Patients. Zacherl MJ, Gildehaus FJ, Mittlmeier L, Boning G, et al. J Nucl Med 2021;62:669-674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zacherl MJ, Gildehaus FJ, Mittlmeier L, Boning G, et al. First Clinical Results for PSMA-Targeted alpha-Therapy Using (225)Ac-PSMA-I&T in Advanced-mCRPC Patients. J Nucl Med 2021;62:669-674.
PMID: 33008928